May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Integrin 5ß1 in Choroidal Neovascular Membranes Associated With Age–Related Macular Degeneration
Author Affiliations & Notes
  • A. Vogel
    Ophthalmology, University, Bonn, Germany
  • G. Zahn
    Jerini AG, Berlin, Germany
  • F.G. Holz
    Ophthalmology, University, Bonn, Germany
  • K.U. Loeffler
    Ophthalmology, University, Bonn, Germany
  • Footnotes
    Commercial Relationships  A. Vogel, Jerini AG Berlin, Germany, F; G. Zahn, Jerini AG Berlin, Germany, E; F.G. Holz, Jerini AG Berlin, Germany, F; K.U. Loeffler, Jerini AG Berlin, Germany, F.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5051. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Vogel, G. Zahn, F.G. Holz, K.U. Loeffler; Integrin 5ß1 in Choroidal Neovascular Membranes Associated With Age–Related Macular Degeneration . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5051.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To determine the presence and evaluate the possible role of integrin α5ß1 in neovascular tissue associated with age–related macular degeneration (AMD).

Methods: : Paraffin sections of 7 formalin–fixed choroidal neovascular membranes (CNV) which were removed during subretinal surgery for neovascular AMD were investigated. As a positive control for neovascularization in other ocular samples, similarly processed tissue from 3 pyogenic granulomas was used. Furthermore, sections from 6 eyes enucleated for end–stage glaucoma (one of which, in addition, revealed a typical AMD lesion) were also examined, in particular with regard to the presence of integrin α5ß1 in normal choroidal vessels and choriocapillaries. Immunohistochemistry was performed using 3 different antibodies (Abs) to integrin α5ß1 (2 polyclonal and 1 monoclonal) as well as Abs to Factor VIII (endothelial cell marker), CD68 (macrophage marker) and CK 18 (RPE cell marker) on adjacent sections for comparison. The reaction product was visualized using AEC.

Results: : In pyogenic granuloma, there was intense labeling with anti–integrin α5ß1 of all endothelial cells as well as some macrophages/inflammatory cells within the stroma. This was confirmed by a similar reaction using anti–Factor VIII and anti–CD68 on adjacent sections. Sections from the enucleated eyes all revealed some anti–integrin α5ß1 immunoreactivity in normal choroidal vessels while choriocapillary vessels were mostly negative. In CNV, anti–integrin α5ß1 labeling was seen in most vascular structures and was more prominent than in normal choriocapillaries but less intense compared to labeling with anti–Factor VIII. Individual cells, most likely of macrophage origin, were also stained but even more prominent labeling was found in retinal pigment epithelial (RPE) cells within these membranes. This staining pattern was similar in the eye with AMD while no significant labeling of RPE cells away from the lesion (presumably normal RPE) nor in RPE cells in glaucomatous eyes was seen.

Conclusions: : New vessels in CNV exhibit more prominent anti–integrin α5ß1 immunoreactivity compared to normal choriocapillaries. The difference appears even more striking with regard to RPE cells from AMD lesions compared to normal RPE. From our findings we therefore conclude that an upregulation of integrin α5ß1 in RPE cells might play an important role in the development of CNV associated with AMD.

Keywords: pathology: human • immunohistochemistry • choroid: neovascularization 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.